New mRNA-based flu vaccine from Moderna approved for older adults
Moderna's groundbreaking mRNA-based flu vaccine has received FDA approval and will be available for the upcoming flu season. This represents a significant advancement in flu vaccine technology, as it is the first mRNA flu shot to be approved by the FDA. The new vaccine is specifically designed to meet the needs of older adults.
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
Comments
0No comments yet. Say what you noticed in the coverage.
Trending